2nd International Conference on Women’s Health, Gynecology and Obstetrics June 12-13, 2019 Osaka, Japan

Biography:

DR  NABILA EAJAZ has completed her graduation from Nishter hospital,multan and is currently working as a post graduate trainee in Nishter hospital obstetrics and gynaecology department in FCPS OBS. AND GYNAECOLOGY.

Abstract:

Biography:

Growth strategy consultant, marketing expert and sought-after public speaker Rachel Braun Scherl is a trusted authority on leadership and entrepreneurship. As Managing Partner and Co-Founder (1998) of SPARK Solutions for Growth in, a consulting firm advising businesses on strategic growth and partnerships, product development and marketing, Rachel has built an international client base that includes multiple divisions of Johnson & Johnson, Allergan, Pfizer, Merck, Bayer and Church & Dwight. In 2008, Rachel and her business partner collaborate to create Semprae Laboratories. As President, Rachel and her team built a company that developed and marketed sexual health and wellness products for women - creating a new category in the process. Semprae attracted significant media attention and industry interest and was sold to Innovus Pharmaceuticals in 2013.

Abstract:

How do you talk about important health issues or facts of life if you can’t use their actual names? The women's health industry has faced this dilemma for decades—life-changing products like tampons or vaginal dryness solutions can’t use words like “vagina” explicitly in ads or on vital consumer marketing platforms like Facebook. Imagine educating consumers about contact lenses or saline solution without being able to use the word "eye." Rachel will discuss the importance of having a common vocabulary in the pursuit of effectively marketing “taboo” topics such as vaginal health, how to create language for the complexity of female sexuality, and why it’s important for today’s leaders and biggest brands to destigmatize pressing health and aging concerns for women. Rachel is a dynamic, passionate business leader and a pioneer in the space. As a respected strategist and entrepreneur, she has successfully launched, built and turned around companies, both large and small. After building and selling a female sexual health company called Semprae, Rachel now focuses on arming entrepreneurs who are targeting this sphere, with the wisdom, insight and knowledge to succeed. Rachel speaks to health and business leaders about the trials, tribulations, travesties, and triumphs that she and others have experienced fighting to bring awareness and easy access to women for products and services designed to meet a range of needs. She shares both business advice and perseverance from a leader who is well-versed in the world of women’s sexual health and wellness and many of the leaders/companies paving the way.

Biography:

Dr. Shiela Mae D. Putol finished her residency training at East Avenue Medical Center in Quezon City, Philippines. She is currently a Medical Specialist in Obstetrics and Gynecology in Lanao del Norte Provincial Hospital, Philippines

Abstract:

Preeclampsia, which is defined as elevated blood pressure after 20 weeks of pregnancy in a woman whose blood pressure had been normal, remains the second most common cause of direct maternal deaths (0.83 per 100,000 cases) worldwide. At present, no effective prophylactic measures have been identified in the prevention of preeclampsia and other pregnancy complications such as intrauterine growth restriction. Therefore, proper antenatal care remains the most important part of prevention. Identifying each woman’s individualized risk can allow further antenatal surveillance to be directed to those women who are most likely to develop preeclampsia. Such care leads to early diagnosis and intervention, both in terms of maternal/ fetal monitoring and timing of delivery. In this study, uterine artery Doppler velocimetry in the mid-trimester will be analyzed, and its role in the prediction of later pregnancy complications (preeclampsia and intrauterine growth restriction) will be discussed. The aim of this study is to predict the risk for the development of adverse pregnancy outcomes on the basis of mid-trimester uterine artery Doppler velocimetry. Statistical analysis showed that preeclampsia occurred significantly more commonly in the group with an abnormal doppler result at 16-22 weeks of gestation, compared to pregnancies with normal doppler findings. That is 42.9% (3 out of 7) for abnormal doppler result versus 7.2% (2 out of 27) for those with normal doppler findings. However, none of the 34 evaluated cases developed intrauterine growth restriction. Abnormal uterine artery Doppler result at 16-22 weeks is associated with adverse pregnancy outcomes. In this study, it was well correlated with the development of preeclampsia. Hence, uterine artery Doppler can be used as a useful method for identifying high-risk pregnancies. Uterine artery pulsatility index (PI >1.45) can provide further information for the prediction of preeclampsia in order to conduct appropriate clinical interventions to avoid perinatal morbidity

Biography:

Mo Zhou was born in 1993 and now is a year 2 PhD student in occupational therapy in University of Newcastle, Australia. In 2017, she finished Master of Public Health (Health Services Research) in University of Sheffield. In 2014, she finished Bachelor of Public Health Management in Guangzhou University of Chinese Medicine. In 2012, she gained the Qualification of Senior Public Nutritionist (National Vocational Qualification Level-Three). Her main research field is family health and nursing.

Abstract:

China has been one of the highest caesarean section rate countries in the world. Caesarean section rate in China appears to experience an increasing trend in the recent years and would continue in the following years. This review aimed to analyse the current trends and prevalence of caesarean section rate in China, as well as the main individual social factors, finally provide some suggestions to control and reduce caesarean section rate. 8 databases including WHO STATISTICS, HUFFINGTONPOST, OECD HEALTH STATISTICS, CHINADMD, CHINAGOV, PCBABY, Google Scholar and CNKI were employed by using key words to obtain journal articles which are related to the research questions. The search returned 181 articles. Based on the inclusion and exclusion criteria, 156 articles were finally selected in this review. Findings illustrated that the prevalence of caesarean section rate in China has risen and differed based on whether women and their family are from rural or urban areas in the last twenty years, also this trend would keep upward in both urban and rural areas in the next ten years. This review also demonstrated that the factors could be broadly divided into two categories: demand-side factors (education, income and health insurance of Chinese women) and supply-side factors (doctors’ recommendations). Finally, the review provided some recommendations such as employing Robson classification, establishing salary incentives to control caesarean section rate in China.